Literature DB >> 17882263

Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation.

Alexander Golks1, Thi-Thanh Thao Tran, Jean Francois Goetschy, Danilo Guerini.   

Abstract

The dynamic modification of nuclear and cytoplasmic proteins with O-linked beta-N-acetylglucosamine (O-GlcNAc) by the O-linked N-acetylglucosaminyltransferase (OGT) is a regulatory post-translational modification that is responsive to various stimuli. Here, we demonstrate that OGT is a central factor for T- and B-lymphocytes activation. SiRNA-mediated knockdown of OGT in T cells leads to an impaired activation of the transcription factors NFAT and NFkappaB. This results in a reduction of IL-2 production consistent with prevention of T-cell activation. OGT is also required for the early activation of B cells mediated by stimulation of the B-cell receptor. Mechanistically, we demonstrate that NFkappaB as well as NFAT are glycosylated with O-GlcNAc after direct binding to OGT. Moreover, kinetic experiments show that O-GlcNAc modification prominently increased shortly after activation of lymphoid cells and it might be required for nuclear translocation of the transcription factors NFkappaB and NFAT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882263      PMCID: PMC2034663          DOI: 10.1038/sj.emboj.7601845

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis.

Authors:  Chad Slawson; Natasha E Zachara; Keith Vosseller; Win D Cheung; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2005-07-18       Impact factor: 5.157

2.  Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.

Authors:  Won Ho Yang; Ji Eun Kim; Hyung Wook Nam; Jung Won Ju; Hoe Suk Kim; Yu Sam Kim; Jin Won Cho
Journal:  Nat Cell Biol       Date:  2006-09-10       Impact factor: 28.824

3.  Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates.

Authors:  Brooke D Lazarus; Dona C Love; John A Hanover
Journal:  Glycobiology       Date:  2006-01-23       Impact factor: 4.313

4.  Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta.

Authors:  X Cheng; R N Cole; J Zaia; G W Hart
Journal:  Biochemistry       Date:  2000-09-26       Impact factor: 3.162

5.  The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny.

Authors:  R Shafi; S P Iyer; L G Ellies; N O'Donnell; K W Marek; D Chui; G W Hart; J D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  The role of CAP3 in CD95 signaling: new insights into the mechanism of procaspase-8 activation.

Authors:  A Golks; D Brenner; I Schmitz; C Watzl; A Krueger; P H Krammer; I N Lavrik
Journal:  Cell Death Differ       Date:  2006-03       Impact factor: 15.828

Review 7.  Cell signaling, the essential role of O-GlcNAc!

Authors:  Natasha E Zachara; Gerald W Hart
Journal:  Biochim Biophys Acta       Date:  2006-05-06

8.  Hsp90 is essential for the synthesis and subsequent membrane association, but not the maintenance, of the Src-kinase p56(lck).

Authors:  M J Bijlmakers; M Marsh
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

9.  Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.

Authors:  Y Gao; L Wells; F I Comer; G J Parker; G W Hart
Journal:  J Biol Chem       Date:  2001-01-08       Impact factor: 5.157

10.  A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout.

Authors:  John A Hanover; Michele E Forsythe; Patrick T Hennessey; Thomas M Brodigan; Dona C Love; Gilbert Ashwell; Michael Krause
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-28       Impact factor: 11.205

View more
  93 in total

1.  O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.

Authors:  Heberty T Facundo; Robert E Brainard; Lewis J Watson; Gladys A Ngoh; Tariq Hamid; Sumanth D Prabhu; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-09       Impact factor: 4.733

2.  Enzymatic extract from Ecklonia cava induces the activation of lymphocytes by IL-2 production through the classical NF-κB pathway.

Authors:  Ginnae Ahn; Eunjin Park; Won-Woo Lee; Jin-Won Hyun; Ki-Wan Lee; Taekyun Shin; You-Jin Jeon; Youngheun Jee
Journal:  Mar Biotechnol (NY)       Date:  2010-05-18       Impact factor: 3.619

Review 3.  Chemical approaches to understanding O-GlcNAc glycosylation in the brain.

Authors:  Jessica E Rexach; Peter M Clark; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2008-02       Impact factor: 15.040

Review 4.  The O-linked N-acetylglucosamine modification in cellular signalling and the immune system. 'Protein modifications: beyond the usual suspects' review series.

Authors:  Alexander Golks; Danilo Guerini
Journal:  EMBO Rep       Date:  2008-07-11       Impact factor: 8.807

5.  NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions.

Authors:  Won Ho Yang; Sang Yoon Park; Hyung Wook Nam; Do Hyun Kim; Jeong Gu Kang; Eun Seok Kang; Yu Sam Kim; Hyun Chul Lee; Kwan Soo Kim; Jin Won Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

6.  Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code.

Authors:  Kaoru Sakabe; Zihao Wang; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-02       Impact factor: 11.205

Review 7.  Too sweet to resist: Control of immune cell function by O-GlcNAcylation.

Authors:  Tristan de Jesus; Sudhanshu Shukla; Parameswaran Ramakrishnan
Journal:  Cell Immunol       Date:  2018-06-02       Impact factor: 4.868

Review 8.  O-GlcNAc: a novel regulator of immunometabolism.

Authors:  Miranda Machacek; Chad Slawson; Patrick E Fields
Journal:  J Bioenerg Biomembr       Date:  2018-02-06       Impact factor: 2.945

Review 9.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

Review 10.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.